Prosecution Insights
Last updated: November 04, 2026
Application No. 19/130,365

Targeted Temperature Management Thermal Contact Pad with Data Chip

Non-Final OA §102§103§Other
Filed
May 15, 2025
Priority
Nov 18, 2022 — nonprovisional of PCTUS2022050498 +1 more
Examiner
SMITH, KAITLYN ELIZABETH
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medivance Incorporated
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
2y 0m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
482 granted / 829 resolved
-11.9% vs TC avg
Moderate +15% lift
Without
With
+15.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
35 currently pending
Career history
871
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
45.0%
+5.0% vs TC avg
§102
18.8%
-21.2% vs TC avg
§112
23.8%
-16.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 829 resolved cases

Office Action

§102 §103 §Other
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Objections Applicant is advised that should claim 5 be found allowable, claim 8 will be objected to under 37 CFR 1.75 as being a substantial duplicate thereof. When two claims in an application are duplicates or else are so close in content that they both cover the same thing, despite a slight difference in wording, it is proper after allowing one claim to object to the other as being a substantial duplicate of the allowed claim. See MPEP § 608.01(m). Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 14-16 and 18 is/are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by US 2012/0172956 A1 to Dewaegenaere (Dewaegenaere). Regarding claim 14, Dewaegenaere teaches a thermal pad configuration (therapeutic pad 10) for placement on a patient, comprising a fluid compartment configured to receive a TTM fluid from a TTM module to facilitate thermal energy transfer between the TTM fluid and the patient ([0071] which states in part “circulating fluid to read a therapeutic pad” and [0072] which states in part “circulation of the fluid from a thermal treatment device through the connectors (202, 204) to and through the therapeutic pad (10).”) configured to receive a TTM fluid from a TTM module to facilitate thermal energy transfer between the TTM fluid and the patient and a memory chip (a readable and writeable electronic memory chip, e.g. the data storage 310) attached to the thermal pad (Fig. 7), the memory chip configured to wirelessly exchange data with a console of the TTM module ([0073-0074]). Regarding claim 15, Dewaegenaere teaches the pad of claim 14 as well as the pad data including a status of the fluid compartment ([0056]) and the status includes one of an empty state ([0056]) or a full state. Regarding claim 16, Dewaegenaere teaches the pad of claim 15 as well as wherein the status of the fluid compartment is changeable by logic of the console between the empty sate and the full state ([0056-0059]). Regarding claim 18, Dewaegenaere teaches the pad of claim 14 as well as wherein the pad data include indemnification information including one or more types of thermal pad ([0047]), a model number, a size, a serial number ([0046]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-4 and 11-13 is/are rejected under 35 U.S.C. 103a as being unpatentable over Dewaegenaere in view of US 2003/0074038 A1 to Gruszecki et al. (Gruszecki). Regarding claim 1, Dewaegenaere teaches a target temperature management (TTM) system (Fig. 7), comprising a TTM module (medical treatment device (100) configured to provide a TTM fluid ([0071]), the TTM module including a console (hardware and software user interface 104) having a processor (316) and memory (318), including a non-transitory computer-readable medium, having logic stored thereon that, when executed by the processor performs operations of the system ([0043] which states in part “a computer program product is provided. The computer program product has one or more computer readable media having computer executable instructions for performing the steps of the method…”), and a thermal pad (therapeutic pad 10) having a fluid compartment ([0071] which states in part “circulating fluid to read a therapeutic pad” and [0072] which states in part “circulation of the fluid from a thermal treatment device through the connectors (202, 204) to and through the therapeutic pad (10).”) configured to receive the TTM fluid from the TTM module to facilitate thermal energy transfer between the TTM fluid and the patient, wherein the TTM module is configured to deliver TTM fluid to the thermal pad to transition the fluid compartment from an empty state to a full state (inherent in the start of the procedure) and the thermal pad includes a memory chip (a readable and writeable electronic memory chip, e.g. the data storage 310) having stored thereon pad data including a status of the fluid compartment ([0044] which states “In a particular embodiment, the data is a medical protocol information and/or a result of a medical treatment and/or an information relating to the performance and/or lifetime of the pad.”; [0075] which states “the thermal treatment device will start writing data onto the data storage tag (310). Once the treatment stops, and the user moves to another location, the therapeutic pad (10) will be connected to a new thermal treatment device. The latter will read the information from the data storage tag (310), and by doing so it will be able to implement the right treatment protocol without needing any manual input.”; [0078] which states “Also, because the thermal treatment device will also log on the data storage tag (310) information related to the therapeutic pad (10) performance, usage, quality, etc., the thermal treatment device will be able to control and regulate the use of expired or non-performing therapeutic pads (10).”), the memory chip communicatively coupled with the console ([0073]), and the operations include exchanging pad data with the memory ship ([0073-0074]). However, Dewaegenaere does not explicitly teach the TTM module configured to extract TTM fluid from the thermal pad to transition the fluid compartment from the full state to the empty state. Gruszecki teaches an analogous targeted temperature management system (title “Patient Temperature Control System with Fluid Preconditioning”) including a purge mode that automatically functions to empty water from the pads ([0107]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Dewaegenaere to include the purge mode for emptying the pad as taught by Gruszecki to allow for the thermal fluid to be removed from the device when treatment is completed or the pad needs to be disconnected as an obvious matter of engineering design choice. Regarding claim 2, the combination teaches the system of claim 1 as well as Dewaegenaere teaching wherein the status of the fluid compartment includes at least one of the empty state ([0056]) or the full state. Regarding claim 3, the combination teaches the system of claim 1 as well as Dewaegenaere teaching wherein the operations further include receiving the status of the fluid compartment from the memory ship ([0073-0074]). Regarding claim 4, the combination teaches the system of claim 1 as well as Dewaegenaere teaching wherein the operations further include transmitting at least a portion of the pad data to the memory chip ([0073-0074]). Regarding claim 11, the combination teaches the system of claim 2 as well as Dewaegenaere teaching wherein the operations include transitioning the status of the fluid compartment from the empty state to the full state ([0056-0059]). Regarding claim 12, the combination teaches the system of claim 2 as well as Dewaegenaere teaching wherein the operations include transitioning the status of the fluid compartment from the full state to the empty state ([0056-0059]). Regarding claim 13, the combination teaches the system according to claim 1 as well as wherein the pad data include indemnification information including one or more types of thermal pad ([0047]), a model number, a size, a serial number ([0046]). Claim(s) 5 and 8 is/are rejected under 35 U.S.C. 103a as being unpatentable over Dewaegenaere and Gruszecki as applied to claim 1 and further in view of US 2019/0133820 A1 to Jacobsen et al. (Jacobsen). Regarding claims 5 and 8, Dewaegenaere in view of Gruszecki teaches the system of claim 1, but not wherein the pad data includes a fluid capacity of the fluid compartment. Jacobsen teaches an analogous device (title “Devices, Systems and Methods for Endovascular Temperature Control “) that includes encoded information of the changeable components that is embedded in a chip or microchip mounted on the changeable components ([0008]), where the information includes volume of the changeable components ([0008]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Dewaegenaere to include data related to the volume of the pad so as to provide the user with the fluid requirements of the connected components. Claim(s) 17 is/are rejected under 35 U.S.C. 103a as being unpatentable over Dewaegenaere in view of Jacobsen. Regarding claim 17, Dewaegenaere in view of Gruszecki teaches the pad of claim 14, but not wherein the pad data includes a fluid capacity of the fluid compartment. Jacobsen teaches an analogous device (title “Devices, Systems and Methods for Endovascular Temperature Control “) that includes encoded information of the changeable components that is embedded in a chip or microchip mounted on the changeable components ([0008]), where the information includes volume of the changeable components ([0008]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Dewaegenaere to include data related to the volume of the pad so as to provide the user with the fluid requirements of the connected components. Allowable Subject Matter Claims 6, 7, 9 and 10 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art as set forth above does not teach the operations as set forth in claims 6, 7, 9 and 10. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAITLYN E SMITH whose telephone number is (571)270-5845. The examiner can normally be reached Monday-Friday 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne M Rodden can be reached at (303) 297-4726. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KAITLYN E SMITH/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

May 15, 2025
Application Filed
Oct 01, 2026
Non-Final Rejection mailed — §102, §103, §Other (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778797
Soft Border for Targeted Temperature Management
3y 3m to grant Granted Nov 03, 2026
Patent 12773344
Cooling/Heating Medical Pad with Softened Edges
3y 3m to grant Granted Oct 27, 2026
Patent 12734066
Systems, Apparatus and Methods for Leak Prevention with Targeted Temperature Management Gel Pads
4y 2m to grant Granted Sep 15, 2026
Patent 12734353
SYSTEMS AND METHODS FOR TREATMENT OF A PATIENT INCLUDING RF AND ELECTRICAL ENERGY
2y 7m to grant Granted Sep 15, 2026
Patent 12714596
THERMALLY CONTROLLED FACE ENGAGING DEVICE
3y 8m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
73%
With Interview (+15.0%)
3y 6m (~2y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 829 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month